Skip to main content
RecallsAboutBlog

Ajanta Pharma USA Inc

Ajanta Pharma USA Inc: 4 recalls listed since June 2026 across FDA.

By year

  • 20264

By agency

  • FDA4

By category

  • Drug4

All recalls (4)

Ajanta Pharma Ranolazine Extended-Release Tablets

Ranolazine Extended-Release Tablets fail dissolution specifications.

Moderate risk, FDA, , Drug dissolving problem

Ajanta Pharma Fluphenazine Hydrochloride Tablets

Fluphenazine Hydrochloride Tablets failed impurity specifications during stability testing.

Low risk, FDA, , Drug impurity

Ajanta Pharma Fenofibrate Capsules

Fenofibrate Capsules, USP 200 mg, have CGMP deviations.

Moderate risk, FDA, , Manufacturing problem

Ajanta Pharma Aripiprazole Tablets

Aripiprazole Tablets USP are mislabeled, containing Voriconazole Tablets instead.

Moderate risk, FDA, , Labeling error
Embed this list